Objective: Our study aimed at assessing the quality of life (QoL) of patients treated for chronic heart failure (HF), and analyzing the impact of certain factors on that QoL, in the cardiology department of Yalgado Ouédraogo University Hospital of Ouagadougou. Means and Method: It was a descriptive cross-sectional study, performed over a six-month period from May to October 2016. In the study, patients with age over 18 years were included, followed up for chronic HF for at least six months in the outpatient unit, from January 1 st to December 31 st 2015. The questionnaire "Minnesota Living with
Introduction
Heart failure (HF) is a major cause of disability with significant impairment of quality of life (QoL), which is rated by the patients themselves. Due to the chronic and usually irreversible nature of HF, assessment of QoL is of great interest. According to the World Health Organization (1994), QoL is defined as the individual's perception of his position in life, in the context of culture and value system in which he has been living, in relation to his objectives, his expectations, his standards and his concerns [1] . The basic point of this definition is the notion of perception, which means that the patient's opinion is primordial.
Physiological methods of evaluation such as stress tests, have been used as replacement means to measure QoL without much reliability [2] . Direct means of measure such as the questionnaire of the University of Minnesota were developed to meet this need; this widely used questionnaire enables the assessment of the disease and treatments' effects on the QoL of patients suffering from HF [2] .
Unlike the developed countries, studies on the QoL of patients suffering from HF are scarce in Africa [3] [4] . No study has been performed on this issue in Burkina Faso even though QoL has become a major concern in health sector.
Taking QoL into account is a rightful wish of the medical community, to know how patients live with their disease.
Our study aimed at assessing QoL of patients suffering from chronic HF in the cardiology department of Yalgado Ouédraogo University Hospital (YOUH) of Ouagadougou.
Methods
It was a descriptive cross-sectional study performed on patients reviewed from May 1 st to October 31 st 2015, on outpatient basis in the cardiology department of YOUH of Ouagadougou. Patients above 18 years, with chronic HF and under medical treatment for at least six months, were included in the study. We excluded the patients with acute cardiac decompensation requiring hospitalization; Open Access Library Journal those with unstable angina or who had myocardial infarction within the last six months; those on treatment for cancer; those on hemodialysis, and those with cognitive disorders. QoL has been assessed through the "Minnesota Living with Heart Failure" (MLHF) questionnaire [2] . This questionnaire has been developed to explore how HF and its treatments can affect the physical, emotional, social and mental dimensions of a patient's life over the past four weeks. Each of the 21 items of the questionnaire was marked by the patient on a Likert type score scale, from zero to five according to the increasing degree of disturbance on lifestyle. The sum of the answers to the 21 items, ranging from zero to 105 enabled the assessment of the patient's overall QoL. Eight items with a total score ranging from zero to 40 enabled the assessment of the physical dimension of the patient's QoL, while the sum of the answers to five other items (total from zero to 25) enabled the assessment of the emotional dimension of the patient's QoL. The higher the cores, the more impaired the patient's QoL; the lower the scores, the better the QoL. [5] , while pulmonary artery hypertension meant a SPAP > 40 mmHg [7] .
Patients enrolled in the study after giving their informed consent, were invited at the outpatient unit for data collection. Confidentiality and anonymity were Data confidentiality was considering when collecting data and data anonymity has been respected. The local ethical committee was approved this study.
Results
204 patients with chronic HF were included in the study. Table 2 shows the so- 
Discussion
HF affects QoL of patients in different ways: by weakening physical performances due to asthenia and dyspnea; by giving way to mood disorders due to In our study, QoL was significantly more impaired in men in its overall dimension. However, most studies which used the MLHF questionnaire reported the opposite [6] [11] [16] [21] . These gender-related differences could derive from the responsibilities assigned to each partner of a couple, based on the system of value peculiar to the society they've been living in.
QoL in all dimensions was more significantly impaired among patients from rural or semi urban area compare to those living in Ouagadougou. Challenges in Open Access Library Journal accessibility to a specialist and therapeutic discontinuations due to drugs unavailability in remote areas could explain this situation. In our study, socioeconomic and educational levels did not significantly influenced QoL. Barbareschi in the Netherlands [22] , Clark in the USA [23] and Lee in Hong Kong [24] demonstrated that QoL was significantly better among HF patients with high socio-economic and/or educational level. According to these authors, deprived patients and those with low educational level are more exposed and more vulnerable to stressful situations, are less compliant to treatments and often have tenuous health condition. In our context, these effects are probably counterbalanced by the great socio-familial support provided to our patients.
Severe or end-stage renal failure in our patients with HF, was associated to a poor QoL on the emotional dimension. Indeed, some studies reported that the presence of co-morbidities significantly impaired the QoL of HF patients [6] [13] [16] , probably due to the additive noxious effects of combined chronic pathologies.
We observed significantly impaired QoL in all three dimensions, among patients with SBP lower than 100 mmHg. Lewis in the USA [25] and Rodriguez in Some studies found significant improvement of MLHF questionnaire scores under HF-specific beta-blockers [3] [30] [31] . However, Wilson et al. [32] , the Open Access Library Journal RESOLVD study [33] as well as our study did not find any significant change in the QoL of patients under beta-blockers. These differences could be related to the type of studies and the type of beta-blockers that were used. Anyway, the effects of HF-specific beta-blockers on the reduction of morbi-mortality are nowadays unquestionable [34] .
Conclusions
Our study reported that more than 70% of patients with HF in the cardiology 
